Clinical Trial Update: Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hydromorphone hydrochloride extended-release versus placebo in adults with persistent chronic non-malignant pain has been terminated; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-malignant Pain

Drugs mentioned

• Hydromorphone hydrochloride extended-release (hydromorphone hydrochloride extended-release)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Chronic Non-Malignant Pain | Phase 3 | Status: TERMINATED